FDA proposes 180-day transition before terminating COVID-19 EUAs, enforcement policies
Regulatory NewsMichael Mezher • Joanne S. Eglovitch
Diagnostics/IVDsMedical DevicesNorth AmericaProduct LifecycleRegulatory NewsMichael Mezher • Joanne S. EglovitchDiagnostics/IVDsMedical DevicesNorth AmericaProduct Lifecycle